Elevation of Lung Surfactant Phosphatidylcholine in Mouse Models of Sandhoff and of Niemann-Pick A Disease

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 2005 Jan 27

PMID 15669680

Citations 7

Authors

R Buccoliero

L Ginzburg

A H Futerman

Affiliations

Soon will be listed here.

Abstract

Sandhoff disease is caused by the defective activity of the lysosomal enzyme beta-hexosaminidase, resulting in accumulation of the glycolipids, GA2 and GM2. Niemann-Pick A/B disease is caused by the defective activity of lysosomal acid sphingomyelinase resulting in sphingomyelin accumulation. Pulmonary complications have been observed in both diseases. We now demonstrate changes in phospholipid levels in pulmonary surfactant in mouse models of these diseases. In the Hexb mouse, a model of Sandhoff disease, lipid phosphate levels were elevated in surfactant from 3- and 4-month-old mice, which was mainly due to elevated levels of phosphatidylcholine. In the ASM mouse, a model of Niemann-Pick A disease, levels of the primary storage material, sphingomyelin, were elevated as expected, and levels of phosphatidylcholine and two other phospholipids were also significantly elevated in pulmonary surfactant and in lung tissue from 5-, 6- and 7-month-old mice. These results suggest that changes in phospholipid levels and composition in lung surfactant might be a general feature of sphingolipid storage diseases, which may be in part responsible for the increased susceptibility of these patients to respiratory infections and lung pathology, often the main reason for the death of these patients.

Citing Articles

Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse.

Paget T, Parkinson-Lawrence E, Trim P, Autilio C, Panchal M, Koster G Cells. 2021; 10(4).

PMID: 33918094 PMC: 8070179. DOI: 10.3390/cells10040849.

Platform Effects on Regeneration by Pulmonary Basal Cells as Evaluated by Single-Cell RNA Sequencing.

Greaney A, Adams T, Raredon M, Gubbins E, Schupp J, Engler A Cell Rep. 2020; 30(12):4250-4265.e6.

PMID: 32209482 PMC: 7175071. DOI: 10.1016/j.celrep.2020.03.004.

Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.

Yu F, Islam D, Sikora J, Dworski S, Gurka J, Lopez-Vasquez L Am J Physiol Lung Cell Mol Physiol. 2017; 314(3):L406-L420.

PMID: 29167126 PMC: 5900354. DOI: 10.1152/ajplung.00223.2017.

Mutation of Serine 32 to Threonine in Peroxiredoxin 6 Preserves Its Structure and Enzymatic Function but Abolishes Its Trafficking to Lamellar Bodies.

Sorokina E, Dodia C, Zhou S, Tao J, Gao L, Raabe T J Biol Chem. 2016; 291(17):9268-80.

PMID: 26921317 PMC: 4861491. DOI: 10.1074/jbc.M115.698894.

Using ASMase knockout mice to model human diseases.

Hua G, Kolesnick R Handb Exp Pharmacol. 2013; (216):29-54.

PMID: 23563650 PMC: 7121422. DOI: 10.1007/978-3-7091-1511-4_2.

References

Nicholson A, Wells A, Hooper J, Hansell D, Kelleher A, Morgan C . Successful treatment of endogenous lipoid pneumonia due to Niemann-Pick Type B disease with whole-lung lavage. Am J Respir Crit Care Med. 2002; 165(1):128-31. DOI: 10.1164/ajrccm.165.1.2103113. View

Bodennec J, Koul O, Aguado I, Brichon G, ZWINGELSTEIN G, Portoukalian J . A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J Lipid Res. 2000; 41(9):1524-31. View

Bodennec J, Brichon G, ZWINGELSTEIN G, Portoukalian J . Purification of sphingolipid classes by solid-phase extraction with aminopropyl and weak cation exchanger cartridges. Methods Enzymol. 2000; 312:101-14. DOI: 10.1016/s0076-6879(00)12902-7. View

Lever A, RYDER J . Cor pulmonale in an adult secondary to Niemann-Pick disease. Thorax. 1983; 38(11):873-4. PMC: 459683. DOI: 10.1136/thx.38.11.873. View

HEPPLESTON A, McDermott M, Collins M . The surface properties of the lung in rats with alveolar lipo-proteinosis. Br J Exp Pathol. 1975; 56(5):444-53. PMC: 2072780. View

Pelled D, Lloyd-Evans E, Riebeling C, Jeyakumar M, Platt F, Futerman A . Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J Biol Chem. 2003; 278(32):29496-501. DOI: 10.1074/jbc.M302964200. View

BARTLETT G . Phosphorus assay in column chromatography. J Biol Chem. 1959; 234(3):466-8. View

Trajkovic-Bodennec S, Bodennec J, Futerman A . Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes. Blood Cells Mol Dis. 2004; 33(1):77-82. DOI: 10.1016/j.bcmd.2004.03.001. View

Ferretti G, Lantuejoul S, Brambilla E, Coulomb M . Case report. Pulmonary involvement in Niemann-Pick disease subtype B: CT findings. J Comput Assist Tomogr. 1996; 20(6):990-2. DOI: 10.1097/00004728-199611000-00023. View

10.

Seymour J, Presneill J . Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002; 166(2):215-35. DOI: 10.1164/rccm.2109105. View

11.

Seeger W, Gunther A, Walmrath H, Grimminger F, Lasch H . Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clin Investig. 1993; 71(3):177-90. PMC: 7096084. DOI: 10.1007/BF00180100. View

12.

Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M . Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med. 1996; 153(1):176-84. DOI: 10.1164/ajrccm.153.1.8542113. View

13.

Tredano M, de Blic J, Griese M, Fournet J, Elion J, Bahuau M . Clinical biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism. Clin Chem Lab Med. 2001; 39(2):90-108. DOI: 10.1515/CCLM.2001.018. View

14.

Green G . Alveolobronchiolar transport mechanisms. Arch Intern Med. 1973; 131(1):109-14. View

15.

Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H . Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet. 1995; 11(2):170-6. DOI: 10.1038/ng1095-170. View

16.

Horinouchi K, Erlich S, Perl D, Ferlinz K, Bisgaier C, Sandhoff K . Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet. 1995; 10(3):288-93. DOI: 10.1038/ng0795-288. View

17.

Ikegami M, Dhami R, Schuchman E . Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Am J Physiol Lung Cell Mol Physiol. 2002; 284(3):L518-25. DOI: 10.1152/ajplung.00258.2002. View

18.

Bewig B, Wang X, Kirsten D, Dalhoff K, Schafer H . GM-CSF and GM-CSF beta c receptor in adult patients with pulmonary alveolar proteinosis. Eur Respir J. 2000; 15(2):350-7. DOI: 10.1034/j.1399-3003.2000.15b22.x. View

19.

Lewis J, Jobe A . Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993; 147(1):218-33. DOI: 10.1164/ajrccm/147.1.218. View

20.

Niggemann B, Rebien W, Rahn W, Wahn U . Asymptomatic pulmonary involvement in 2 children with Niemann-Pick disease type B. Respiration. 1994; 61(1):55-7. DOI: 10.1159/000196305. View